An era is coming to an end. Statins, the world’s most widely prescribed and profitable drugs, have, with the exception Crestor (rosuvastatin), all come off patent and their price has plummeted. Good news for NHS accountants not so good for company profits. (Read more…)

This week we bring you a shocking warning about a new danger linked with statins. Did you know that they stimulate the production of something called P9 which can not only damage the liver but also actually makes statins less effective? Nor did we. (Read more…)